INVESTOR OVERVIEW

Corporate Profile

Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity. More >>

Recent NewsMore >>
05/30/19
Rhythm Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference
05/07/19
Rhythm Pharmaceuticals to Present at Bank of America Merrill Lynch 2019 Health Care Conference
05/03/19
Rhythm Pharmaceuticals Reports First Quarter 2019 Financial Results
RYTM (Common Stock) $22.830.00 (0.00%)06/17/19 4:00 p.m. ET
Stock chart for: RYTM.O.  Currently trading at $22.83 with a 52 week high of $37.23 and a 52 week low of $22.02.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources
Upcoming EventsMore >>
There are currently no events scheduled.